Strategic partnerships Cogentix Medical has a history of partnerships and acquisitions, including distribution deals and a notable acquisition by Laborie. Opportunities exist to pursue co-development or distribution agreements for EndoSheath Endoscopy solutions, Urgent PC neuromodulation systems, or Macroplastique across new regions or healthcare channels.

Urology and pelvic health focus Primary market segments are voiding dysfunction, overactive bladder, female stress urinary incontinence, and endoscopy. Target hospitals, ambulatory surgery centers, and specialty clinics focusing on pelvic health and minimally invasive procedures to expand adoption of Urgent PC and endoscopy products.

Regulatory ready Products are FDA-cleared and prescription-only, highlighting a need for clinical adoption strategies, reimbursement navigation, and physician education programs to accelerate adoption in eligible U.S. and international sites.

Growth through device portfolio A diversified product line including neuromodulation, bulking agents, and disposable endoscopy barriers presents cross-sell opportunities with urology and gynecology practitioners. Consider bundled offers or multi-product trials to grow ticket size per account.

Growth potential regions Past regional distribution activities and partnerships suggest appetite for expansion in international markets. Identify high-volume urology and pelvic health centers abroad and propose regional distribution, service, and training packages to accelerate market penetration.